Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04316312
Other study ID # 201912165RINB
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 12, 2021
Est. completion date March 31, 2021

Study information

Verified date April 2021
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the activation patterns of diaphragm and sternocleidomastoid (SCM) muscle during different loaded inspiratory muscle performance in patients with COPD after acute exacerbation. Null hypothesis (H0): There is no significant difference between activation pattern of diaphragm and SCM muscle during different loaded inspiratory muscle performance in patients with COPD after acute exacerbation. Alternative hypothesis (H1): There is significant difference between activation pattern of diaphragm and SCM muscle during different loaded inspiratory muscle performance in patients with COPD after acute exacerbation.


Description:

The prevalence of chronic obstructive pulmonary disease (COPD) is 11.7% around the world, and it is expected to rise over the next 30 years. In Taiwan, COPD is estimated as the seventh leading cause of death in 2016, and has been gradually increasing in the past decades. COPD has been long considered to be a disease state characterized by airflow limitation that are not fully reversible, leading to abnormalities in control of breathing, worsening of respiratory mechanics and pulmonary function. However, COPD is no longer considered to affect only the lungs and airways, but also the rest of the body including decreases in respiratory and limb-muscle mass and function. When acute exacerbation occurs, lung function decreases rapidly. According to the previous studies, inspiratory muscle training (IMT), can improve the strength and endurance of the diaphragm, reduce dyspnea and breathing pattern, thus increasing the capacity of activities tolerance in patients with COPD. Although more and more studies are focus on diaphragm weakness and the effect of IMT in patients with COPD, the efficacy and intensity of IMT in patients with COPD is still controversial and the clinical use is limited. Whether increases intensity during IMT would lead to improvements in contraction pattern of respiratory muscle remained unclear. Therefore, the purpose of this study is to assess the activation patterns of diaphragm and sternocleidomastoid (SCM) muscle during different loaded inspiratory muscle performance in patients with COPD after acute exacerbation.


Recruitment information / eligibility

Status Completed
Enrollment 1
Est. completion date March 31, 2021
Est. primary completion date March 31, 2021
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - age > 20 years old - has been diagnosis of chronic obstructive pulmonary disease and experienced at least 2 times of acute exacerbation in recent 6 months - can cooperate with the measurements of this study Exclusion Criteria: - any clinical diagnosis that will influence the measurement, including any history of neuromyopathy - angina, acute myocardial infarction in the previous one month - pregnancy - participated in inspiratory muscle training program in the previous three months - any psychiatric or cognitive disorders, for example: Mini-Mental State Examination (MMSE) < 24, that will disturb the communication and cooperation of the study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Threshold inspiratory muscle trainer
Threshold inspiratory muscle trainer will be set between 15% to 30% of maximal inspiratory pressure.

Locations

Country Name City State
Taiwan School and Graduate Institute of Physical Therapy of National Taiwan University Taipei Zhongzheng Dist

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diaphragm and Sternocleidomastoid muscle activation The surface electromyography (EMG) signal was analyzed in the time domain, calculating root mean square (RMS) amplitude with a time constant of 30 mini seconds. A 1.5 seconds window of diaphragm and SCM muscle signals at peak pressure during maximal inspiratory pressure test were obtained and calculated as maximal effort. Diaphragm and SCM activation were calculated using mean RMS values of each threshold loaded breathing test, and then normalized to maximal effort (%EMGDia and %EMGSCM). through the completion of the maximal inspiratory pressure test and loaded inspiratory muscle test condition; totally it would take about 3 minutes
Secondary The mean median frequency of diaphragm and sternocleidomastoid muscle The power spectrum is divided into two equal areas of the frequency value by median frequency to exam muscle fatigue. In one minute after the completion of the loaded inspiratory muscle test condition
See also
  Status Clinical Trial Phase
Completed NCT04044625 - Effects of High-intensity Noninvasive Positive Pressure Ventilation in AECOPD N/A
Active, not recruiting NCT03751670 - Pulmonary Rehabilitation During Acute Exacerbations of Chronic Obstructive Pulmonary Disease: a Mixed-methods Approach N/A
Completed NCT03083418 - The Effect of EDP on Diaphragmatic Function and Neural Respiratory Drive in Patient With AECOPD N/A
Recruiting NCT04183530 - The Individualized Accurate Diagnosis and Treatment of Chronic Objective Pulmonary Disease(COPD) Patients Based on Multidimensional Data
Enrolling by invitation NCT06189586 - Comparison of Aerosol Inhalation and Intravenous Glucocorticoid in the Treatment of Severe AECOPD N/A
Recruiting NCT06134063 - A Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease N/A
Not yet recruiting NCT06114667 - Nasal High Flow Versus Non-invasive Ventilation for Early Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Hypercapnic Acidosis N/A
Not yet recruiting NCT05222711 - The Use of a Monitoring Device by General Practitioners During Out-of-hours Care N/A
Recruiting NCT05480566 - Functional Strength Training and Neuromuscular Electrical Stimulation in Severe Acute Exacerbations of COPD N/A
Terminated NCT02985918 - High-Intensity vs Low-Intensity NPPV in Patients With an AECOPD: The HAPPEN Trial N/A
Recruiting NCT06175065 - Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Phase 2
Recruiting NCT04259736 - Prospective Cohort Study of Molecular Mechanism of Lower Respiratory Tract Microbes in Patients With AECOPD
Completed NCT03633838 - Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China
Completed NCT02051166 - Clinical Practice of AECOPD Management in China N/A
Recruiting NCT04212182 - The Physiological Effect of High Flow Oxygen Therapy N/A
Recruiting NCT04101500 - Effect of Compound Sodium Chlorate and Aminophylline Tablets on Chronic Obstructive Pulmonary Disease(COPD). Phase 4